EPISODE · Jan 10, 2023 · 7 MIN
Tuesday, January 10, 2023
from The Gist Healthcare Podcast
Gist Healthcare joins healthcare management consultancy group Kaufman Hall. Biogen’s latest Alzheimer’s drug lecanemab was granted accelerated approval by the FDA. And, the FTC has proposed a ban on non-compete agreements, which could impact how the healthcare industry operates. That's coming up on today's episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
Gist Healthcare joins healthcare management consultancy group Kaufman Hall. Biogen’s latest Alzheimer’s drug lecanemab was granted accelerated approval by the FDA. And, the FTC has proposed a ban on non-compete agreements, which could impact how the healthcare industry operates. That's coming up on today's episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
Tuesday, January 10, 2023
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m